Physiologically based pharmacokinetic modelling of acute digoxin toxicity and the effect of digoxin-specific antibody fragments-Reference-Cited by-同舟云学术

Physiologically based pharmacokinetic modelling of acute digoxin toxicity and the effect of digoxin-specific antibody fragments

Published:2018-10-11 Issue:2 Volume:57 Page:117-124
ISSN:1556-3650
Container-title:Clinical Toxicology
language:en
Short-container-title:Clinical Toxicology

Author:

Bracken Lucy M.¹²^ORCID,Chan Betty S. H.²³^ORCID,Buckley Nicholas A.¹³^ORCID

Affiliation:

1. Pharmacology, Sydney Medical School, University of Sydney, Sydney, Australia;

2. Department of Emergency Medicine, Clinical Toxicology Unit, Prince of Wales Hospital, New South Wales, Australia;

3. New South Wales Poisons Information Centre, New South Wales, Australia

Funder

NHMRC Program

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15563650.2018.1503288

Reference26 articles.

1. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning

2. Management of digoxin toxicity

3. Fab Antibody Fragments

4. U.S. Food and Drug Administration[internet]. Prescribing information for Digoxin Oral Solution. 2011; Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021648s004lbl.pdf.

5. Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors’ reply to comment on: clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning;Clinical Toxicology;2021-12-14

2. Pharmacological aspects of acute treatment glycoside intoxication;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2021-08-28

3. Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6);Clinical Toxicology;2021-08-23